Novavax Inc.

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

45.40%

Market Cap

1.30 Bil.

P/E Ratio

2.64

Dividend Yield

0.00 %

Earnings per Share

2.25 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE7.89 G0 Units
PRICE DETERMINATION TIME06/19/2026 / 09:56:49 PM
DAILY VOLUME (UNITS)400
DAILY HIGH / LOW8.017.89
PREV. DAY'S PRICE8 (06/18)
CHANGE DAY BEFORE
-0.11
-1.38 %
52 WEEK HIGH / LOW10.054 (02/26)5.351 (07/01)
More Price Information

Key Figures (in EUR)

2027e2026e202520242023
EARNINGS PER SHARE-0.29-0.452.25-1.14-5.00
DIVIDENDS PER SHARE0.000.000.000.000.00
DIVIDEND YIELD IN %--0.00 %0.00 %0.00 %
DIVIDEND GROWTH IN %-----
PRICE - EARNINGS RATIO--2.64--
PRICE - BOOK RATIO-----
PRICE - SALES RATIO--1.041.790.49
PRICE - CASH FLOW RATIO-----
Further Key Figures

Master Data

WKN
A2PKMZ
ISIN
US6700024010
SYMBOL
NVV1
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
Novavax
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
US Dollar
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
164.44 Mil.
MARKET CAPITALISATION
1.30 Bil.

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
2.04 %
4.58 %
-8.47 %
44.74 %
45.40 %
8.70 %
-94.51 %
39.47 %
HIGH8.629.859.8510.0510.0523.80232.3510.05
LOW7.607.256.555.645.353.413.415.65
Dividend
per share
Novavax does not deliver dividend information

Company profile

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.